Finance

Lists
Q2 2026 earnings • released • EPS beat +8.03% • Revenue beat +93.78%
See results
ALEC:NASDAQ
Alector Inc
$1.78
-2.73%
(-0.050) 1D
$1.88
+5.52% (+0.098)
After hours
Closed: Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALEC...
Open
$1.84
High
$2.00
Low
$1.74
Mkt. cap
197.62M
Avg. vol.
854.61K
Volume
1.25M
52-wk high
$3.40
52-wk low
$1.09
EPS
-$1.19
Beta
0.60
Shares outstanding
111.02M
No. of employees
103
Open
$1.84
High
$2.00
Low
$1.74
Mkt. cap
197.62M
Avg. vol.
854.61K
Volume
1.25M
52-wk high
$3.40
52-wk low
$1.09
EPS
-$1.19
Beta
0.60
Shares outstanding
111.02M
No. of employees
103
News stories
From sources across the web
About Alector Inc
CEO-
Employees103
Founded2013
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitealector.com
Analyst ratings
Based on 5 analysts giving stock ratings to ALEC in the past 3 months
Hold
Buy
1
Hold
3
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ALEC in the last 3 months.
Highest
Current $1.78
$5.00 (+180.90%)
Average
$2.50 (+40.45%)
Lowest
$1.00 (-43.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Fein
H.C. Wainwright
Buy
Maintained
$5.00
+180.9%
08/07/2026
Alec Stranahan
Bank of America Securities
Sell
Reiterated
$1.00
-43.8%
08/07/2026
Yaron Werber
TD Cowen
Hold
Maintained
-
-
08/06/2026
Myles Minter
William Blair
Hold
Reiterated
-
-
08/07/2026
Graig Suvannavejh
Mizuho Securities
Hold
Maintained
$1.50
-15.7%
07/09/2026
Sean Laaman
Morgan Stanley
Sell
Maintained
$2.00
+12.4%
05/04/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Upgraded
-
-
04/15/2026
Thomas Shrader
BTIG
Buy
Maintained
$6.00
+237.1%
04/02/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.21 / -$0.23
+8.03%beat
Revenue / Est. (USD)
3.32M / 1.71M
+93.78%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.26M
6.24M
1.05M
3.32M
Cost of goods sold
29.35M
32.46M
17.86M
-
Cost of revenue
29.35M
32.46M
17.86M
-
Research and development expenses
-
-
-
19.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.52M
10.42M
8.11M
8.25M
Operating expense
11.52M
10.42M
8.11M
27.71M
Total operating expenses
40.87M
42.88M
25.96M
27.71M
Operating income
-37.61M
-36.64M
-24.92M
-24.39M
Other non operating income
2.94M
1.22M
1.32M
1.53M
EBT including unusual items
-34.67M
-37.10M
-22.93M
-22.86M
EBT excluding unusual items
-34.67M
-35.42M
-23.60M
-22.86M
Income tax expense
-
168.00K
-
130.00K
Effective tax rate
-
-0.45%
-
-0.57%
Other operating expenses
-
-
-
-
Net income
-34.67M
-37.27M
-22.93M
-22.99M
Net profit margin
-1,063.40%
-597.51%
-2,192.16%
-692.47%
Earnings per share
-0.34
-0.34
-0.21
-0.21
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.37M
-35.48M
-23.84M
-23.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps